Using Drosophila as a tool to identify pharmacological therapies for fragile X syndrome

Jacquemont, 2007, Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1, Lancet Neurol., 6, 45, 10.1016/S1474-4422(06)70676-7 Hagerman, 2012, Fragile X syndrome and targeted treatment trials, Results Probl. Cell Differ., 54, 297, 10.1007/978-3-642-21649-7_17 McBride, 2012, Behavior in a Drosophila model of fragile X, Results Probl. Cell Differ., 54, 83, 10.1007/978-3-642-21649-7_6 Tessier, 2012, Molecular and genetic analysis of the Drosophila model of fragile X syndrome, Results Probl. Cell Differ., 54, 119, 10.1007/978-3-642-21649-7_7 O‘Donnell, 2002, A decade of molecular studies of fragile X syndrome, Annu. Rev. Neurosci., 25, 315, 10.1146/annurev.neuro.25.112701.142909 Hatton, 2006, Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP, Am. J. Med. Genet. A, 140A, 1804, 10.1002/ajmg.a.31286 Zafeiriou, 2007, Childhood autism and associated comorbidities, Brain Dev., 29, 257, 10.1016/j.braindev.2006.09.003 Sutcliffe, 1992, DNA methylation represses FMR-1 transcription in fragile X syndrome, Hum. Mol. Genet., 1, 397, 10.1093/hmg/1.6.397 Verkerk, 1991, Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome, Cell, 65, 905, 10.1016/0092-8674(91)90397-H Ashley, 1993, FMR1 protein: conserved RNP family domains and selective RNA binding, Science, 262, 563, 10.1126/science.7692601 Wan, 2000, Characterization of dFMR1: a Drosophila melanogaster homolog of the fragile X mental retardation protein, Mol. Cell. Biol., 20, 8536, 10.1128/MCB.20.22.8536-8547.2000 Darnell, 2009, Discrimination of common and unique RNA-binding activities among fragile X mental retardation protein paralogs, Hum. Mol. Genet., 18, 3164, 10.1093/hmg/ddp255 Zhang, 2001, Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function, Cell, 107, 591, 10.1016/S0092-8674(01)00589-X Morales, 2002, Drosophila fragile X protein: DFXR, regulates neuronal morphology and function in the brain, Neuron, 34, 961, 10.1016/S0896-6273(02)00731-6 Dockendorff, 2002, Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest, Neuron, 34, 973, 10.1016/S0896-6273(02)00724-9 Inoue, 2002, A role for the Drosophila fragile X-related gene in circadian output, Curr. Biol.: CB, 12, 1331, 10.1016/S0960-9822(02)01036-9 McBride, 2005, Pharmacological rescue of synaptic plasticity: courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome, Neuron, 45, 753, 10.1016/j.neuron.2005.01.038 Dolen, 2005, Courting a cure for fragile X, Neuron, 45, 642, 10.1016/j.neuron.2005.02.021 Bhogal, 2010, Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention, Dis. Model. Mech., 3, 693, 10.1242/dmm.002006 Berry-Kravis, 2008, Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome, J. Dev. Behav. Pediatr., 29, 293, 10.1097/DBP.0b013e31817dc447 Jacquemont, 2011, Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056, Sci. Transl. Med., 3, 64ra1, 10.1126/scitranslmed.3001708 Yan, 2005, Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP, Neuropharmacology, 49, 1053, 10.1016/j.neuropharm.2005.06.004 Dolen, 2007, Correction of fragile X syndrome in mice, Neuron, 56, 955, 10.1016/j.neuron.2007.12.001 Siller, 2011, Neural circuit architecture defects in a Drosophila model of fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase, Dis. Model. Mech., 4, 673, 10.1242/dmm.008045 Bilousova, 2009, Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model, J. Med. Genet., 46, 94, 10.1136/jmg.2008.061796 Yuskaitis, 2010, Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome, Biochem. Pharmacol., 79, 632, 10.1016/j.bcp.2009.09.023 Min, 2009, Elevated glycogen synthase kinase-3 activity in fragile X mice: key metabolic regulator with evidence for treatment potential, Neuropharmacology, 56, 463, 10.1016/j.neuropharm.2008.09.017 Dickson, 2008, Wired for sex: the neurobiology of Drosophila mating decisions, Science, 322, 904, 10.1126/science.1159276 Siwicki, 2003, Associative learning and memory in Drosophila: beyond olfactory conditioning, Behav. Process., 64, 225, 10.1016/S0376-6357(03)00137-2 Griffith, 2009, Courtship learning in Drosophila melanogaster: diverse plasticity of a reproductive behavior, Learn. Mem., 16, 743, 10.1101/lm.956309 Tauber, 2011, Elevated levels of the vesicular monoamine transporter and a novel repetitive behavior in the Drosophila model of fragile X syndrome, PLoS One, 6, e27100, 10.1371/journal.pone.0027100 Quinn, 1974, Conditioned behavior in Drosophila melanogaster, Proc. Natl. Acad. Sci. U. S. A., 71, 708, 10.1073/pnas.71.3.708 Dudai, 1976, dunce: a mutant of Drosophila deficient in learning, Proc. Natl. Acad. Sci. U. S. A., 73, 1684, 10.1073/pnas.73.5.1684 Jellies, 1981 Tully, 1985, Classical conditioning and retention in normal and mutant Drosophila melanogaster, J. Comp. Physiol. A, 157, 263, 10.1007/BF01350033 Davis, 1993, Mushroom bodies and Drosophila learning, Neuron, 11, 1, 10.1016/0896-6273(93)90266-T Tully, 1994, Genetic dissection of consolidated memory in Drosophila, Cell, 79, 35, 10.1016/0092-8674(94)90398-0 Skoulakis, 2006, Dunces and da Vincis: the genetics of learning and memory in Drosophila, Cell. Mol. Life Sci., 63, 975, 10.1007/s00018-006-6023-9 Bolduc, 2008, Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory, Nat. Neurosci., 11, 1143, 10.1038/nn.2175 Siegel, 1979, Conditioned responses in courtship behavior of normal and mutant Drosophila, Proc. Natl. Acad. Sci. U. S. A., 76, 3430, 10.1073/pnas.76.7.3430 Hall, 1994, The mating of a fly, Science, 264, 1702, 10.1126/science.8209251 Hall, 1979, Control of male reproductive behavior by the central nervous system of Drosophila: dissection of a courtship pathway by genetic mosaics, Genetics, 92, 437, 10.1093/genetics/92.2.437 Tompkins, 1983, Conditioned courtship in Drosophila and its mediation by association of chemical cues, Behav. Genet., 13, 565, 10.1007/BF01076402 Tompkins, 1982, The role of female movement in the sexual behavior of Drosophila melanogaster, Behav. Genet., 12, 295, 10.1007/BF01067849 Tompkins, 1984, Genetic analysis of sex appeal in Drosophila, Behav. Genet., 14, 411, 10.1007/BF01065443 Ackerman, 1986, Chemically reinforced conditioned courtship in Drosophila: responses of wild-type and the dunce, amnesiac and don giovanni mutants, J. Neurogenet., 3, 111, 10.3109/01677068609106898 Siwicki, 2005, The role of cuticular pheromones in courtship conditioning of Drosophila males, Learn. Mem., 12, 636, 10.1101/lm.85605 Ejima, 2005, Sequential learning of pheromonal cues modulates memory consolidation in trainer-specific associative courtship conditioning, Curr. Biol., 15, 194, 10.1016/j.cub.2005.01.035 Ejima, 2007, Generalization of courtship learning in Drosophila is mediated by cis-vaccenyl acetate, Curr. Biol., 17, 599, 10.1016/j.cub.2007.01.053 McBride, 1999, Mushroom body ablation impairs short-term memory and long-term memory of courtship conditioning in Drosophila melanogaster, Neuron, 24, 967, 10.1016/S0896-6273(00)81043-0 Choi, 2010, Age-dependent cognitive impairment in a Drosophila fragile X model and its pharmacological rescue, Biogerontology, 11, 347, 10.1007/s10522-009-9259-6 Banerjee, 2010, Short- and long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein, J. Neurosci., 30, 6782, 10.1523/JNEUROSCI.6369-09.2010 He, 2012, The trouble with spines in fragile X syndrome: density, maturity and plasticity, Neuroscience, 10.1016/j.neuroscience.2012.03.049 Restifo, 2005, Mental retardation genes in Drosophila: new approaches to understanding and treating developmental brain disorders, Ment. Retard. Dev. Disabil. Res. Rev., 11, 286, 10.1002/mrdd.20083 Pan, 2004, The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation, Curr. Biol., 14, 1863, 10.1016/j.cub.2004.09.085 Yin, 1994, Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila, Cell, 79, 49, 10.1016/0092-8674(94)90399-9 Berry-Kravis, 1992, Cyclic AMP metabolism in fragile X syndrome, Ann. Neurol., 31, 22, 10.1002/ana.410310105 Berridge, 1993, Inositol trisphosphate and calcium signalling, Nature, 361, 315, 10.1038/361315a0 Lakin-Thomas, 1993, Effects of inositol starvation on the levels of inositol phosphates and inositol lipids in Neurospora crassa, Biochem. J., 292, 805, 10.1042/bj2920805 Berry-Kravis, 1995, Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations, Pediatr. Res., 38, 638, 10.1203/00006450-199511000-00002 Berry-Kravis, 1998, Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells, J. Neurosci. Res., 51, 41, 10.1002/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L Bullock, 1998, Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity: conformation, and increases net charge, Biochemistry, 37, 3795, 10.1021/bi970982t Inoue, 1998, Type 1 inositol 1,4,5-trisphosphate receptor is required for induction of long-term depression in cerebellar Purkinje neurons, J. Neurosci., 18, 5366, 10.1523/JNEUROSCI.18-14-05366.1998 Takei, 1998, Regulation of nerve growth mediated by inositol 1,4,5-trisphosphate receptors in growth cones, Science, 282, 1705, 10.1126/science.282.5394.1705 Bear, 2004, The mGluR theory of fragile X mental retardation, Trends Neurosci., 27, 370, 10.1016/j.tins.2004.04.009 Huber, 2002, Altered synaptic plasticity in a mouse model of fragile X mental retardation, Proc. Natl. Acad. Sci. U. S. A., 99, 7746, 10.1073/pnas.122205699 Choi, 2011, Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment, Brain Res., 1380, 106, 10.1016/j.brainres.2010.11.032 Pan, 2007, Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A convergently regulate the synaptic ratio of ionotropic glutamate receptor subclasses, J. Neurosci., 27, 12378, 10.1523/JNEUROSCI.2970-07.2007 Pan, 2008, Mechanistic relationships between Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A signaling, Mol. Cell. Neurosci., 37, 747, 10.1016/j.mcn.2008.01.003 Moldin, 2005, Understanding fragile X syndrome: molecular, cellular and genomic neuroscience at the crossroads, Genes Brain Behav., 4, 337, 10.1111/j.1601-183X.2005.00150.x Moldin, 2006, Can autism speak to neuroscience?, J. Neurosci.: Off. J. Soc. Neurosci., 26, 6893, 10.1523/JNEUROSCI.1944-06.2006 Walsh, 2008, Autism and brain development, Cell, 135, 396, 10.1016/j.cell.2008.10.015 Volkmar, 2009, Autism and autism spectrum disorders: diagnostic issues for the coming decade, J. Child Psychol. Psychiatry Allied Discipl., 50, 108, 10.1111/j.1469-7610.2008.02010.x Raymond, 2006, The genetics of mental retardation, Hum. Mol. Genet., 15, R110, 10.1093/hmg/ddl189 State, 2010, The genetics of child psychiatric disorders: focus on autism and Tourette syndrome, Neuron, 68, 254, 10.1016/j.neuron.2010.10.004 Michalon, 2012, Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice, Neuron, 74, 49, 10.1016/j.neuron.2012.03.009 Chang, 2008, Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila, Nat. Chem. Biol., 4, 256, 10.1038/nchembio.78 Gantois, 2006, Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model, Neurobiol. Dis., 21, 346, 10.1016/j.nbd.2005.07.017 Sanchez, 2005, Rolipram impairs NF-kappaB activity and MMP-9 expression in experimental autoimmune encephalomyelitis, J. Neuroimmunol., 168, 13, 10.1016/j.jneuroim.2005.03.024 Martin-Chouly, 2004, Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors, Life Sci., 75, 823, 10.1016/j.lfs.2004.01.021 Oger, 2005, Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin E2 production and matrix metalloproteinase-9 activity in human amniochorionic membranes, J. Immunol., 174, 8082, 10.4049/jimmunol.174.12.8082 Liu, 2005, Effect of glutamine on the expression of grp75 in PC12 cells, Shi Yan Sheng Wu Xue Bao, 38, 423 Paribello, 2010, Open-label add-on treatment trial of minocycline in fragile X syndrome, BMC Neurol., 10, 91, 10.1186/1471-2377-10-91